JP Morgan Chase’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
PCM
JP Morgan Chase's BCAT Position: Q2 2025 in Review
JP Morgan Chase sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 277 shares — an estimated $3.99K sold.
JP Morgan Chase first reported a position in BCAT in Q4 2022 and held it in 8 quarters. The position peaked at $1.67M in Q1 2023. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.
- JP Morgan Chase reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
- JP Morgan Chase sold 277 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $3.99K.
- JP Morgan Chase first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 8 quarters.
- JP Morgan Chase's BlackRock Capital Allocation Term Trust position peaked at $1.67M in Q1 2023.
- 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.